Oncology Business Management | Specialty

The OncLive Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.

Don't Let Physician Burnout Threaten Your Practice's Health

April 11th 2017

Results of a study indicate that 44.7% of practicing oncologists show signs of burnout.

Oncology Value Reformer Seeks AMA Post

April 10th 2017

Barbara McAneny, MD, hopes she can help fix American healthcare’s shortcomings while also promoting its strengths by running for president of the American Medical Association (AMA).

The Good, the Bad, and the Unknown

April 4th 2017

When it comes to achievements in the war against cancer, there’s much to celebrate, ASCO said in its fourth annual report on the state of cancer care in America, which we discuss in our lead story this month for Oncology Business ManagementTM.

FDA Submission Completed for Axicabtagene Ciloleucel in NHL

April 1st 2017

A biologics license application has been submitted for axicabtagene ciloleucel as a potential treatment for transplant ineligible patients with relapsed or refractory aggressive non-Hodgkin lymphoma.

Clarifying the Role of Oncology Nurse Navigators

April 1st 2017

Tricia Strusowski, MS, RN, discusses the role of the oncology nurse navigator and how these staffers can help meet outcome and quality standards set by the CMS's OCM.

Dr. Crews Reflects on the Achievements of the ACCC During Her Presidency

March 31st 2017

The outgoing president of the Association of Community Cancer Centers, Jennie Crews, MD, MMM, FACP reflects on her time as president and the achievements the ACCC made.

Federal Healthcare Policy Is Front and Center at CANCERSCAPE Conference

March 31st 2017

While at the annual CANCERSCAPE meeting of ACCC, Kavita Patel, MD, MS, comments on uncertainy in the healthcare environment and key policy to be aware of.

FDA Grants Full Approval to Osimertinib for T790M+ NSCLC

March 31st 2017

The FDA has granted a regular approval to osimertinib as a treatment for patients with metastatic EGFR T790M mutation-positive non–small cell lung cancer following prior treatment with an EGFR TKI, based on progression-free survival findings from the phase III AURA3 trial.

ACCC Calls for Vigilance Despite Repeal Failure

March 30th 2017

The Republican-led Affordable Care Act repeal and replace effort has the potential to be revived, but majority leaders may not want to risk further political capital in a battle that could go against them, speakers said at this year's Association of Community Cancer Centers' CANCERSCAPE annual conference.

ASCO Fights Perception That Independents Get Short Shrift

March 30th 2017

Daniel F. Hayes, MD, and Stephen S. Grubbs, MD, discuss the perception that ASCO has not been truly representative of smaller, independent oncology practices throughout the United States, and how they plan to remedy that.

FDA Grants Priority Review to CTL019 for ALL

March 30th 2017

The FDA has granted a priority review designation to tisagenlecleucel-T as a treamtnet for pediatric and young adult patients with relapsed and refractory B-cell acute lymphoblastic leukemia, making it the first CAR T-cell therapy to enter regulatory review.

FDA Panel Supports Subcutaneous Rituximab for Blood Cancers

March 29th 2017

The FDA's Oncologic Drugs Advisory Committee unanimously (11-0) recommended approval of subcutaneous rituximab for the treatment of patients with certain blood cancers.

ASCO Highlights Challenges, Hope in State of Cancer Care Report

March 22nd 2017

The Affordable Care Act has improved access to cancer care for millions of Americans, and many new drugs and new indications for existing cancer drugs were approved in 2016, but there are frontiers in improving cancer care that include information barriers, disparities in the availability of rural care, and stressors on physicians and oncology practices, ASCO said in its annual report State of Cancer Care in America: 2017.

Binimetinib Application for NRAS-Mutant Melanoma Withdrawn

March 20th 2017

Array BioPharma has withdrawn its new drug application for binimetinib as a treatment for patients with NRAS-mutant advanced melanoma, based on feedback from the FDA during a preplanned review meeting.

Big Data May Guide Future Treatment Decisions

March 17th 2017

The paucity of patients participating in clinical trials makes data extrapolation and application complex, calling for a need to explore health technology solutions that tap the potential of real-world data.

MMR Deficiency Linked to PD-L1 Expression in Endometrial Cancer

March 14th 2017

Mismatch repair-deficient endometrial cancers exhibited significantly higher levels of PD-L1 expression compared with MMR-intact tumors.

Pecora Recognized for Innovation in Medicine

March 14th 2017

Andrew L. Pecora, MD, has been awarded the inaugural Rosemarie J. Sorce Endowed Chair in Innovation at Hackensack Meridian Health.

Study Shows Healthcare Utilization and Costs for mTNBC

March 11th 2017

Healthcare resource use and costs remain high among patients with metastatic triple-negative breast cancer, indicating a need for better targeted treatments for this patient class.

A Change of Horses in Midstream

March 5th 2017

The Affordable Care Act has given rise to healthcare upon which many now depend. Those with an ear to the tracks in Washington, DC, believe that something new is definitely on the way.

Dr. Oh on the Sequencing of New Therapies for Prostate Cancer

February 24th 2017

William K. Oh, MD, chief, Division of Hematology and Medical Oncology, professor of Medicine and Urology, Mount Sinai School of Medicine, discusses sequencing of new therapies for castration-resistant prostate cancer (CRPC).